Breaking News, Financial News

Financial Report: Enzon 3Q

Product sales in the quarter were down 1% to $28.6 million.

Enzon 3Q09

3Q Revenues:
$44.6 million (-9%)

3Q Earnings:
$0.1 million (loss of $2.0 million in 3Q08)

Comments: Product sales in the quarter were down 1% to $28.6 million.
Contract manufacturing revenue was $2.3 million (-57%), primarily due to cancelled shipments and early discontinuation of processing for a CMO customer scheduled for termination in early 2010. Royalty revenue, for which Pegintron accounts for the majority, was $13.7 million (-6%).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters